| 0 (0%) | 11-30 07:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.8 | 1-year : | 2.03 |
| Resists | First : | 1.54 | Second : | 1.74 |
| Pivot price | 1.34 |
|||
| Supports | First : | 1.23 | Second : | 1.02 |
| MAs | MA(5) : | 1.38 |
MA(20) : | 1.35  |
| MA(100) : | 1.56 |
MA(250) : | 1.44 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 48.6 |
D(3) : | 44.4 |
| RSI | RSI(14): 48.6 |
|||
| 52-week | High : | 2.41 | Low : | 1.02 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ATNM ] has closed below upper band by 36.6%. Bollinger Bands are 10.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.47 - 1.48 | 1.48 - 1.48 |
| Low: | 1.36 - 1.37 | 1.37 - 1.38 |
| Close: | 1.44 - 1.45 | 1.45 - 1.46 |
Sat, 29 Nov 2025
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
Sat, 29 Nov 2025
Can ATNM stock hit record highs again - Treasury Yields & Free Weekly Watchlist of Top Performers - moha.gov.vn
Wed, 26 Nov 2025
Actinium Pharmaceuticals elects directors and approves proposals at annual meeting - Investing.com
Wed, 26 Nov 2025
Actinium Pharmaceuticals Holds Annual Stockholders Meeting - MSN
Mon, 17 Nov 2025
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - Newsfile
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 3.037e+007 (%) |
| Held by Institutions | 2 (%) |
| Shares Short | 2,470 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -4.648e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -57 % |
| Return on Assets (ttm) | 665.4 % |
| Return on Equity (ttm) | -31 % |
| Qtrly Rev. Growth | 81000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -586.4 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -1.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -34 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0.14 |
| Dividend | 0 |
| Forward Dividend | 2.22e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|